Bristol Myers Squibb Co. (BMY)
61.15
-0.31
(-0.50%)
USD |
NYSE |
Oct 02, 16:00
61.14
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb Market Cap : 124.93B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 124.93B |
| October 01, 2026 | 125.56B |
| September 30, 2026 | 127.48B |
| September 29, 2026 | 128.42B |
| September 28, 2026 | 130.51B |
| September 25, 2026 | 128.42B |
| September 24, 2026 | 125.64B |
| September 23, 2026 | 124.93B |
| September 22, 2026 | 127.18B |
| September 21, 2026 | 127.93B |
| September 18, 2026 | 128.83B |
| September 17, 2026 | 128.38B |
| September 16, 2026 | 129.93B |
| September 15, 2026 | 130.20B |
| September 14, 2026 | 130.96B |
| September 11, 2026 | 130.02B |
| September 10, 2026 | 130.24B |
| September 09, 2026 | 131.59B |
| September 08, 2026 | 132.16B |
| September 04, 2026 | 136.51B |
| September 03, 2026 | 139.11B |
| September 02, 2026 | 138.23B |
| September 01, 2026 | 136.72B |
| August 31, 2026 | 136.49B |
| August 28, 2026 | 136.02B |
| Date | Value |
|---|---|
| August 27, 2026 | 136.78B |
| August 26, 2026 | 138.05B |
| August 25, 2026 | 138.76B |
| August 24, 2026 | 137.45B |
| August 21, 2026 | 136.90B |
| August 20, 2026 | 133.76B |
| August 19, 2026 | 138.13B |
| August 18, 2026 | 134.94B |
| August 17, 2026 | 132.04B |
| August 14, 2026 | 130.40B |
| August 13, 2026 | 132.08B |
| August 12, 2026 | 130.14B |
| August 11, 2026 | 129.96B |
| August 10, 2026 | 132.47B |
| August 07, 2026 | 132.22B |
| August 06, 2026 | 131.06B |
| August 05, 2026 | 130.00B |
| August 04, 2026 | 134.61B |
| August 03, 2026 | 133.76B |
| July 31, 2026 | 133.43B |
| July 30, 2026 | 132.51B |
| July 29, 2026 | 128.91B |
| July 28, 2026 | 129.93B |
| July 27, 2026 | 127.81B |
| July 24, 2026 | 126.85B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 616.58B |
| Eli Lilly & Co. | 1.076T |
| Merck & Co., Inc. | 356.23B |
| Pfizer Inc. | 158.43B |
| AstraZeneca PLC | 486.65B |
Market Cap Related Metrics
| PE Ratio | 13.47 |
| PS Ratio | 2.540 |
| PEG Ratio | 0.162 |
| Price to Book Value | 5.597 |
| Price to Free Cash Flow | 10.92 |
| Price | 61.15 |
| Earnings Yield | 7.42% |
| PEGY Ratio | 0.1543 |
| Operating PE Ratio | 7.852 |
| Normalized PE Ratio | 9.956 |